A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging

Molecular Imaging and Biology

Volumn 13, Issue 4, 2011, Pages 653-662

  Kalber, Tammy L ^a   Kamaly, Nazila ^a   So, Po Wah ^b   Pugh, John A ^c   Bunch, Josephine ^c   McLeod, Cameron W ^c   Jorgensen, Michael R ^a   Miller, Andrew D ^a   Bell, Jimmy D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Folate; Folate receptor targeting; Gadolinium contrast agents; Low molecular weight contrast agents; MRI contrast agents; Tumor imaging; Tumor MRI

Indexed keywords

FOLATE RECEPTOR; FOLATE RECEPTOR 1; FOLIC ACID; GADOTERATE MEGLUMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL ACTIVITY; CELLULAR DISTRIBUTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; FOLATE METABOLISM; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LASER SURGERY; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR CELL; TUMOR DIAGNOSIS;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; GADOLINIUM; HETEROCYCLIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MOLECULAR WEIGHT; ORGANOMETALLIC COMPOUNDS; SPECTROPHOTOMETRY, ATOMIC; STAINING AND LABELING;

EID: 80052636828     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0400-3     Document Type: Article

References (40)

1. Lucock M (2000) Folic acid: Nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71:121-138
2. Matherly LH, Goldman DI (2003) Membrane transport of folates. Vitam Horm 66:403-456 (Pubitemid 137640823)
3. Antony AC (1996) Folate receptors. Annu Rev Nutr 16:501-521 (Pubitemid 26286863)
4. Campbell IG, Jones TA, Foulkes WD, Trowsdale J (1991) Folate-binding protein is a marker for ovarian cancer. Cancer Res 51:5329-5338
5. Coney LR, Tomassetti A, Carayannopoulos L et al (1991) Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 51:6125-6132
6. Ross JF, Chaudhuri PK, Ratnam M (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73:2432-2443 (Pubitemid 24129130)
7. Luo JSM, Lantrip DA, Wang S, Fuchs PL (1997) Efficient synthesis of pyrofolic acid and pteroyl azide reagents for the production of carboxyldifferentiated derivatives of folic acid. J Am Chem Soc 119:10004-10013 (Pubitemid 27478789)
8. Moon WK, Lin Y, O'Loughlin T et al (2003) Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 14:539-545 (Pubitemid 36597363)
9. Kennedy MD, Jallad KN, Thompson DH, Ben-Amotz D, Low PS (2003) Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J Biomed Opt 8:636-641
10. Chen WT, Khazaie K, Zhang G, Weissleder R, Tung CH (2005) Detection of dysplastic intestinal adenomas using a fluorescent folate imaging probe. Mol Imaging 4:67-74 (Pubitemid 43026019)
11. Kim IB, Shin H, Garcia AJ, Bunz UH (2007) Use of a folate-PPE conjugate to image cancer cells in vitro. Bioconjug Chem 18:815-820 (Pubitemid 47010802)
12. Mathias CJ, Wang S, Waters DJ, Turek JJ, Low PS, Green MA (1998) Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J Nucl Med 39:1579-1585 (Pubitemid 28459891)
13. 99mTc-HYNIC-folate: A novel receptor-based targeted radiopharmaceutical for tumor imaging. J Nucl Med 40:1563-1569 (Pubitemid 29428942)
14. Leamon CP, Parker MA, Vlahov IR et al (2002) Synthesis and biological evaluation of EC20: A new folate-derived, (99m)Tc-based radiopharmaceutical. Bioconjug Chem 13:1200-1210 (Pubitemid 35420011)
15. Reddy JA, Xu LC, Parker N, Vetzel M, Leamon CP (2004) Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. J Nucl Med 45:857-866 (Pubitemid 47618567)
16. 111In-DTPA conjugate of pteroic acid. J Am Chem Soc 127:7421-7426 (Pubitemid 40746027)
17. 18F for PET imaging of folate receptor-positive tumors. J Nucl Med 47:1153-1160 (Pubitemid 47544910)
18. 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting. Eur J Nucl Med Mol Imaging 33:1007-1016 (Pubitemid 44215666)
19. Okarvi SM, Jammaz IA (2006) Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents. Cancer Biother Radiopharm 21:49-60
20. 111In- DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: Initial clinical results. J Nucl Med 44:700-707 (Pubitemid 39655203)
21. Wiener EC, Konda S, Shadron A, Brechbiel M, Gansow O (1997) Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest Radiol 32:748-754 (Pubitemid 28053506)
22. Konda SD, Aref M, Brechbiel M, Wiener EC (2000) Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: Work in progress. Invest Radiol 35:50-57 (Pubitemid 30033607)
23. Konda SD, Wang S, Brechbiel M, Wiener EC (2002) Biodistribution of a 153 Gd-folate dendrimer, generation=4, in mice with folate-receptor positive and negative ovarian tumor xenografts. Invest Radiol 37:199-204 (Pubitemid 34259729)
24. Choi H, Choi SR, Zhou R, Kung HF, Chen IW (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11:996-1004 (Pubitemid 39220809)
25. Sonvico F, Mornet S, Vasseur S et al (2005) Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: Synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem 16:1181-1188 (Pubitemid 41368119)
26. Oyewumi MO, Mumper RJ (2002) Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy. Bioconjug Chem 13:1328-1335 (Pubitemid 35420027)
27. Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD (2009) Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjug Chem 20:648-655
28. Corot C, Robert P, Lancelot E et al (2008) Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting. Magn Reson Med 60:1337-1346
29. Wang ZJ, Boddington S, Wendland M, Meier R, Corot C, Daldrup-Link H (2008) MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatr Radiol 38:529-537
30. Corona G, Giannini F, Fabris M, Toffoli G, Boiocchi M (1998) Role of folate receptor and reduced folate carrier in the transport of 5- methyltetrahydrofolic acid in human ovarian carcinoma cells. Int J Cancer 75:125-133 (Pubitemid 28113987)
31. Rasband WS (1997-2008) ImageJ. U. S. National Institutes of Health, Bethesda. http://rsb.info.nih.gov/ij/
32. Terreno E, Geninatti Crich S, Belfiore S et al (2006) Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn Reson Med 55:491-497 (Pubitemid 43352546)
33. Konda SD, Aref M, Wang S, Brechbiel M, Wiener EC (2001) Specific targeting of folate-dendrimerMRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magma 12:104-113 (Pubitemid 32510128)
34. McHugh M, Cheng YC (1979) Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem 254:11312-11318 (Pubitemid 10136144)
35. Miotti S, Bagnoli M, Ottone F, Tomassetti A, Colnaghi MI, Canevari S (1997) Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines. J Cell Biochem 65:479-491 (Pubitemid 27240914)
36. Paulos CM, Reddy JA, Leamon CP, Turk MJ, Low PS (2004) Ligand binding and kinetics of folate receptor recycling in vivo: Impact on receptor-mediated drug delivery. Mol Pharmacol 66:1406-1414 (Pubitemid 39564767)
37. Nakashima-Matsushita N, Tomma T, Yu S et al (1999) Selective expression of folate receptor-beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 42:1609-1616 (Pubitemid 30263627)
38. Turk MJ, Breur GJ, Widmer WR et al (2002) Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis Reum 46:1947-1955 (Pubitemid 34774528)
39. Turk MJ, Waters DJ, Low PS (2004) Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett 213:165-172 (Pubitemid 39140974)
40. Ayala-Lopez W, Xia W, Varghese B, Low PS (2010) Imaging of atherosclerosis in apoliprotein E knockout mice: Targeting of a folateconjugated radiopharmaceutical to activated macrophages. J Nuc Med 51:768-774